Summary:
Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.
Qualified Participants Must:
Be between 60 and 85 years of age
Have had memory loss for 6 months or more that has become gradually worse over time
Have a family member or close friend who is with you at least 10 hours per week and can attend study appointments with you
Qualified Participants May Receive:
Compensation is available for time and travel